Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Understanding when most people start planning for retirement can help you avoid delays. Find out the trends and best practices for timely planning.
22,030 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Alphabet stock moved higher in a week driven by AI chip ambitions, cloud momentum, and a resilient ad business. This ...
Trump’s affordability proposals are back in focus as he markets cost-of-living relief. The plan faces a crowded legis...
A wave of selling hit AI-related shares after a blog post framed AI gains as 'science fiction.' Behavioral finance ex...
Snowflake's Q4 2026 results set the tone for its growth path in 2027. This analysis breaks down the numbers, the AI-d...
Micron Technology soared 326% in just 12 months, but a sky-high gain doesn’t guarantee a smart buy. This guide breaks...
Rigetti Computing shares slid in a choppy week as inflation jitters and noisy peers weighed on sentiment. This guide ...
A major hedge-like fund reduced its BlackLine stake, sending the stock lower. This article breaks down the why, what ...
Near protocol climbed in a double-digit rally, buoyed by a privacy-first upgrade. Traders debate whether the move sig...
Investors are eyeing a smarter play bitcoin recovery that avoids direct bitcoin ownership while still tapping into th...
The SEC submitted interpretive guidance to OIRA to clarify how federal securities laws could apply to crypto assets. ...
When a notable small-cap manager exits a large stake in a data-security firm, it creates questions for investors. Thi...